Back to search

Article

Seq2Neo: a comprehensive pipeline for cancer neoantigen immunogenicity prediction

2022-09-16

Abstract excerpt

Neoantigens derived from somatic DNA alterations are ideal cancer-specific targets. In recent years, the combination therapy of PD-1/PD-L1 blockers and neoantigen vaccines shows clinical efficacy in original PD-1/PD-L1 blocker non-responders. However, not all somatic DNA mutations can result in immunogenicity in cancer cells, and efficient tools for predicting the immunogenicity of neoepitope are still urgently ne...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
55b5bb3a-cb6d-52dc-a44c-9cfcd6ed29b7
DOI
10.1101/2022.09.14.507872
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Seq2Neo: a comprehensive pipeline for cancer neoantigen immunogenicity predictionDOI 10.1101/2022.09.14.507872
Select a neighboring publication to make it the new centre.